You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi, Inc. is not responsible for the content of the website you are
about to visit.
Go back
You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi, Inc. is not responsible for the content of the website you are
about to visit.
Go back
Discover the Doptelet Copay
Assistance Program
Terms and Conditions
For adults with chronic liver disease (CLD) who have low platelet counts and are preparing for a procedure
If you have CLD, your doctor may have prescribed Doptelet to give your platelet counts a lift to reduce the risk of bleeding before your medical procedure.
Some common side effects of Doptelet (avatrombopag) are fever, headache, and stomach pain. See important safety info below for the full list.
Start taking Doptelet 10 to 13 days prior to your procedure. You and your doctor will work together to decide when your first dose will be. Someone from your care team may contact you as your start date approaches, just to remind you.
Take Doptelet
Once a day
For five days in a row
With any food you like
In case of a missed dose, take the next dose of Doptelet as soon as you remember. Don’t take two at once to make up for a missed dose, just take the next one at the usual time the next day: all 5 days of dosing should be completed.
For more information, take a look at the Doptelet Dosing Guide.
DOPTELET DOSING GUIDEIf you're in need of answers, we've got them! Our Doptelet Advisors can help you navigate your 5 days of Doptelet—just call 855-4-LIFTUP (1-855-454-3887).
Doptelet Connect is one of the ways to help you access treatment. Doptelet Connect can work with you and your doctor to find a pharmacy and get your medication. These steps describe how Doptelet Connect works:
Your doctor sends your prescription to Doptelet Connect
Dedicated Care Coordinators can help:
Dedicated Care Coordinators can help:
A pharmacy will contact you to confirm your delivery details before sending Doptelet to you
Provides the required information to enroll in Doptelet Connect
Facilitates patient/caregiver authorization to enroll in Doptelet Connect
Eligible patients who have commercial insurance may pay as little as $0.
See terms and conditions.
Please call 1-833-368-2663. Care Coordinators are available Monday–Friday 8AM–8PM ET.
INDICATION & IMPORTANT SAFETY INFORMATION
What is DOPTELET (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with long-lasting (chronic) liver disease (CLD) who are scheduled to have a medical or dental procedure.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if DOPTELET passes into breast milk or if DOPTELET may have unintended side effects for your unborn baby. Do not breastfeed during your treatment with DOPTELET and for at least 2 weeks after the last dose.
You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after getting DOPTELET. They can be life threatening or cause death.
Before taking DOPTELET, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.
What are the possible side effects of DOPTELET?
For patients with CLD, the most common side effects are fever, stomach (abdominal) pain, nausea, headache, tiredness, and swelling of the hands or feet.
You Should Know: These are not all of the possible side effects for DOPTELET. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.
If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
What is DOPTELET® (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with long-lasting (chronic) liver disease (CLD) who are scheduled to have a medical or dental procedure.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if
What is DOPTELET (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with long-lasting (chronic) liver disease (CLD) who are scheduled to have a medical or dental procedure.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if DOPTELET passes into breast milk or if DOPTELET may have unintended side effects for your unborn baby. Do not breastfeed during your treatment with DOPTELET and for at least 2 weeks after the last dose.
You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after getting DOPTELET. They can be life threatening or cause death.
Before taking DOPTELET, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.
What are the possible side effects of DOPTELET?
For patients with CLD, the most common side effects are fever, stomach (abdominal) pain, nausea, headache, tiredness, and swelling of the hands or feet.
You Should Know: These are not all of the possible side effects for DOPTELET. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.
If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
This website uses cookies. By continuing to
use this website, you consent to our use of these cookies. Read more about our use of cookies